Annual biologic treatment cost for new and existing patients with moderate to severe plaque psoriasis in Greece

Annual biologic treatment cost for new and existing patients with moderate to severe plaque psoriasis in Greece

Vassilis Fragoulakis,1 Efklidis Raptis,2 Elli Vitsou,2 Nikolaos Maniadakis1 1Health Services Organization and Management, National School of Public Health, 2Pfizer Hellas, Athens, Greece Aim: The aim of the present study was to estimate the annual per-patient cost of treatment with adalimumab, eta...

Full description

Bibliographic Details
Main Authors: Fragoulakis V, Raptis E, Vitsou E, Maniadakis N
Format: Article
Language:English
Published: Dove Medical Press 2015-01-01
Series:ClinicoEconomics and Outcomes Research
Online Access:http://www.dovepress.com/annual-biologic-treatment-cost-for-new-and-existing-patients-with-mode-peer-reviewed-article-CEOR

Internet

http://www.dovepress.com/annual-biologic-treatment-cost-for-new-and-existing-patients-with-mode-peer-reviewed-article-CEOR

Similar Items